Chugai Pharmaceutical Co Ltd
OTC:CHGCF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chugai Pharmaceutical Co Ltd
OTC:CHGCF
|
JP |
|
S
|
Sturm Ruger & Company Inc
F:ST2
|
US |
|
L
|
Lachlan Star Ltd
F:GY6
|
AU |
|
I
|
Infratil Ltd
ASX:IFT
|
NZ |
|
P
|
Pacific Metals Co Ltd
DUS:PYV
|
JP |
|
A
|
Abercrombie & Fitch Co
F:AFT
|
US |
|
Mosenergo PAO
MOEX:MSNG
|
RU |
|
Chelyabinskiy Metallurgicheskiy Kombinat PAO
MOEX:CHMK
|
RU |
|
Tambovskaya Energosbytovaya Kompaniya PAO
MOEX:TASB
|
RU |
|
C
|
Canadian National Railway Co
XMUN:CY2
|
CA |
|
C
|
China Longyuan Power Group Corp Ltd
OTC:CLPXF
|
CN |
|
Vulcan Minerals Inc
F:VM3
|
CA |
|
Humana Inc
NYSE:HUM
|
US |
|
Gecina SA
PAR:GFC
|
FR |
|
N
|
Nippon Kayaku Co Ltd
F:NP7
|
JP |
|
Mavi Giyim Sanayi ve Ticaret AS
IST:MAVI.E
|
TR |
|
H World Group Ltd
F:CL4
|
CN |
|
F
|
Fluor Corp
XMUN:FLU
|
US |
|
B
|
BrainChip Holdings Ltd
OTC:BCHPY
|
AU |
|
Z
|
Zimmer Biomet Holdings, Inc
F:ZIM
|
US |
|
A
|
Advantest Corp
XMUN:VAN
|
JP |
|
S
|
SCI Information Service Inc
KOSDAQ:036120
|
KR |
|
T
|
TSI Co Ltd
KOSDAQ:277880
|
KR |
|
Xtb SA
F:9PR
|
PL |
Intrinsic Value
Is CHGCF undervalued or overvalued?
See the intrinsic value estimate for 
Chugai Pharmaceutical Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Chugai Pharmaceutical Does
Chugai Pharmaceutical is a Japanese drug company that discovers, develops, manufactures, and sells prescription medicines. Its main products are treatments for cancer, immune diseases, blood disorders, bone and joint conditions, and other serious illnesses. The company is focused on medicines that doctors prescribe and hospitals use, not consumer health products.
- Headquarters
- Japan JP
- Employees
- 5 104
- IPO date
- Mar 3, 1956
Chugai Pharmaceutical has a narrow economic moat
Patent protection prevents rivals from freely copying Chugai’s medicines and the antibody technologies used to develop them. Drugs such as Hemlibra turn that protection into sales and licensing income, while its protected research technologies also support the development of new treatments.
Read the full moat analysis
Revenue & Expenses Breakdown
Chugai Pharmaceutical Co Ltd
Earnings Waterfall
Chugai Pharmaceutical Co Ltd
The intrinsic value for Chugai Pharmaceutical Co Ltd (CHGCF) under the Base Case is hidden USD.
Compared with the current market price of 40.738 USD, the stock appears hidden.